Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • SHB
    Junior Member
    • Sep 2011
    • 6

    #1

    E coli de novo sequencing

    We are wanting to do a pathogenomic study of some E coli strains. The idea is basically to compare the genome of these strains between them and against reference genomes and analyse them for virulence factors.

    Among local NGS service providers I found these two options: either Illumina Hiseq2000, paired-ends, or 454. The 454 provider says the expected coverage is about x11-17. I wonder if it is too low? But it also provides a more complete analysis of genomes then the first provider (I'm an "end user", not a bioinformatics expert). The problem of course is cost: 454 is 3 times more expensive.

    Any suggestions or ideas? Anyone dealing with a similiar project that would like to share a bit of his experience?

    Thanks to all and have a nice day
  • colindaven
    Senior Member
    • Oct 2008
    • 417

    #2
    We have done > 20 genomes on 454 titanium but also have a lot of Illumina data. The advantage with 454 is you can do de novo assembly or reference based.

    With Illumina reads the reference based approach would most likely be more relevant for E. coli, because you'd end up with a lot of small contigs after de novo assembly.

    However ref based assembly means you can have difficulties finding new components of the accessory genome. SNP detection vs a reference is very nice though.

    Comment

    • SHB
      Junior Member
      • Sep 2011
      • 6

      #3
      We are really looking for possible new components in the acessory genome and less for SNPs so we are going for de novo sequencing and then genome comparison between strains and ref. genomes.

      Comment

      • pmiguel
        Senior Member
        • Aug 2008
        • 2328

        #4
        Another issue here is that of late I have seen some astounding improvements in de novo assemblers that are real game changers for small genome assembly. Using 10% of a lane of sequence from a HiScanSQ 2x100 run on a simple fragment (PE) TruSeq library assembled with ABySS-PE using kmer 70 we get a reasonable draft sequence.

        By "reasonable" I mean that for 3 Salmonella strains our N50 was >220 kb with 50% of their respective genomes in 8 or 9 contigs. Between 60 and 70 total contigs with sizes 1 kb or larger.

        This is without gap filling or mate-end libraries. Also, these are completely de novo assemblies. (Although, obviously, reference-based assemblies could have been undertaken.)

        --
        Phillip

        Comment

        • krobison
          Senior Member
          • Nov 2007
          • 734

          #5
          Originally posted by pmiguel View Post
          Another issue here is that of late I have seen some astounding improvements in de novo assemblers that are real game changers for small genome assembly. Using 10% of a lane of sequence from a HiScanSQ 2x100 run on a simple fragment (PE) TruSeq library assembled with ABySS-PE using kmer 70 we get a reasonable draft sequence.
          About what fold coverage of reads does this work out to?

          Comment

          • pmiguel
            Senior Member
            • Aug 2008
            • 2328

            #6
            Generally >100X base coverage. In some cases we have overshot and ended up with >200X with a smaller (1 megabase) bacterial genomes--which leads to "embarrassment of riches" with the assembler. (ABySS-PE).

            --
            Phillip

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
              by SEQadmin2



              Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

              Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
              ...
              10-14-2026, 09:55 AM
            • SEQadmin2
              New Genomics Technologies Take Aim at Long-Standing Limits
              by SEQadmin2


              Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

              We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
              ...
              09-28-2026, 10:25 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 10-15-2026, 10:52 AM
            0 responses
            14 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-14-2026, 05:39 AM
            0 responses
            21 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-13-2026, 09:56 AM
            0 responses
            20 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-09-2026, 11:14 AM
            0 responses
            27 views
            0 reactions
            Last Post SEQadmin2  
            Working...